Research over the past decade has suggested important roles for pseudogenes in physiology and disease. In vitro experiments demonstrated that pseudogenes contribute to cell transformation through several mechanisms. However, in vivo evidence for a causal role of pseudogenes in cancer development is lacking. Here, we report that mice engineered to overexpress either the full-length murine B-Raf pseudogene Braf-rs1 or its pseudo "CDS" or "3' UTR" develop an aggressive malignancy resembling human diffuse large B cell lymphoma. We show that Braf-rs1 and its human ortholog, BRAFP1, elicit their oncogenic activity, at least in part, as competitive endogenous RNAs (ceRNAs) that elevate BRAF expression and MAPK activation in vitro and in vivo. Notably, we find that transcriptional or genomic aberrations of BRAFP1 occur frequently in multiple human cancers, including B cell lymphomas. Our engineered mouse models demonstrate the oncogenic potential of pseudogenes and indicate that ceRNA-mediated microRNA sequestration may contribute to the development of cancer.

The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo

ALA, UGO;CHIARLE, Roberto;Pandolfi, Pier Paolo
Last
2015-01-01

Abstract

Research over the past decade has suggested important roles for pseudogenes in physiology and disease. In vitro experiments demonstrated that pseudogenes contribute to cell transformation through several mechanisms. However, in vivo evidence for a causal role of pseudogenes in cancer development is lacking. Here, we report that mice engineered to overexpress either the full-length murine B-Raf pseudogene Braf-rs1 or its pseudo "CDS" or "3' UTR" develop an aggressive malignancy resembling human diffuse large B cell lymphoma. We show that Braf-rs1 and its human ortholog, BRAFP1, elicit their oncogenic activity, at least in part, as competitive endogenous RNAs (ceRNAs) that elevate BRAF expression and MAPK activation in vitro and in vivo. Notably, we find that transcriptional or genomic aberrations of BRAFP1 occur frequently in multiple human cancers, including B cell lymphomas. Our engineered mouse models demonstrate the oncogenic potential of pseudogenes and indicate that ceRNA-mediated microRNA sequestration may contribute to the development of cancer.
161
2
319
332
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922011/
Animals; Base Sequence; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Molecular Sequence Data; Proto-Oncogene Proteins B-raf; RNA; Pseudogenes
Karreth, Florian A; Reschke, Markus; Ruocco, Anna; Ng, Christopher; Chapuy, Bjoern; Léopold, Valentine; Sjoberg, Marcela; Keane, Thomas M; Verma, Akanksha; Ala, Ugo; Tay, Yvonne; Wu, David; Seitzer, Nina; Velasco-Herrera, Martin Del Castillo; Bothmer, Anne; Fung, Jacqueline; Langellotto, Fernanda; Rodig, Scott J; Elemento, Olivier; Shipp, Margaret A; Adams, David J; Chiarle, Roberto; Pandolfi, Pier Paolo
File in questo prodotto:
File Dimensione Formato  
Karreth_BRAF_pseudogene.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 5.43 MB
Formato Adobe PDF
5.43 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Karreth_2015_OA.pdf

Accesso aperto

Descrizione: Karreth 2015 OA
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 1.01 MB
Formato Adobe PDF
1.01 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1530430
Citazioni
  • ???jsp.display-item.citation.pmc??? 137
  • Scopus 244
  • ???jsp.display-item.citation.isi??? 241
social impact